CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE

CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE

Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMOLIGA, JOHN, LORENZ, JON, CERRETA, MICHAEL, BUSACCA, CARL A, VARSOLONA, RICHARD, VITOUS, JANA
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quinolinyl)oxy}éthyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazépin-6-one.